Aspen Neuroscience
Aspen Neuroscience develops autologous iPSC-derived cell replacement therapies for Parkinson’s disease and other CNS disorders.
3
Funding Rounds
$224.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Je**** Lo**** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ho**** J. Fe****** | - | - |
Funding
Funding series
Funding Series Analysis
The company Aspen Neuroscience has raised a total of $154m in funding over 3 rounds.
Key Insights:
- Aspen Neuroscience Series B round, May 2022: $147.5m
- Aspen Neuroscience Seed round, December 2019: $6.5m
- Aspen Neuroscience Series A round Apr 1, 2020: $70m
Aspen Neuroscience Series B round, May 2022
$147.5m
Aspen Neuroscience Seed round, December 2019
$6.5m
Aspen Neuroscience Series A round Apr 1, 2020
$70m
Industries
Aspen Neuroscience is active in the following industries:
- Healthcare
- Biomedical engineering
- Parkinson's disease
- Regenerative medicine
- Biotechnology
- Cell therapy
- Tissue engineering
- Life science
- Stem cell technology
- Engineering
- Autologous stem-cell transplantation
- Neurological disorder
- Biopharmaceutical
- Immunotherapy
- Induced pluripotent stem cell